Searchable abstracts of presentations at key conferences in endocrinology

ea0086p260 | Neuroendocrinology and Pituitary | SFEBES2022

Cushing’s Syndrome – A medical emergency and diagnostic challenge

Thadani Puja , Chaudhury Nadia , Murthy Narasimha , Rao Ranganatha , Randeva Harpal , Weickert Martin , Gholap Nitin

Background: Ectopic Cushing’s syndrome (ECS) is a rare and severe condition at times presenting acutely with intense hypercortisolism. The intensity of hypercortisolism can be disproportionate to underlying tumoral condition, and associated life-threatening complications are common arising suddenly. Hypercortisolism must be controlled rapidly pending definitive treatment of tumoral source to avoid life-threatening consequences.Case Summary: 31-year-...

ea0041ep49 | Adrenal cortex (to include Cushing's) | ECE2016

Cushing’ s disease, hasimoto’s thyroiditis and severe hyperandrogenemia

Valea Ana , Ciocan Irina , Carsote Mara , Morar Andra , Pop Dan Dumitru , Ghervan Cristina , Georgescu Carmen Emanuela

Introduction: Cushing’s disease (CD) is caused by high adrenocorticotropic hormone (ACTH), usually by a pituitary microadenoma.Material and method: This is a case report investigated in several Romanian centers by performing: morning plasma cortisol, circadian rhythm of plasma cortisol, plasma ACTH, dexamethasone (DXM) suppression tests.Case data: A 57-year female, known with hypertension and osteopenia, was ...

ea0037ep19 | Adrenal cortex | ECE2015

Association of psoriasis with Cushing's syndrome

Bahadir Cigdem Tura , Gokosmanoglu Feyzi , Kan Elif Kilic , Ecemis Gulcin Cengiz , Atmaca Aysegul , Atmaca Hulusi , Colak Ramis

Introduction: Psoriasis is a chronic, inflammatory and T-cell mediated autoimmune disease of skin. Its prevalence is 2–3%. It may improve due to immunesupressive effects of hypercortisolaemia during the active phase of Cushing’s syndrome (CS) and may exacerbate after treatment. The aim of this study was to investigate association of psoriasis with CS.Methods: We prospectively followed 62 patients who had been diagnosed with CS between 2010 and ...

ea0037ep37 | Adrenal cortex | ECE2015

Pregnancy-induced Cushing's syndrome

Andreescu Corina , Hofland Leo , Hofland Hans , Looijenga Leendert , de Herder Wouter , Feelders Richard

Cushing’s syndrome (CS) during pregnancy is a rare metabolic condition with only a few cases reported in the literature. Misdiagnosis of CS is common because of the overlapping features of fatigue, weight gain, striae, and emotional changes that occur during normal pregnancy. The clinical presentation together with laboratory and imaging findings help to make a diagnosis. However, changes in maternal hormones and their binding proteins complicate assessment of the normal ...

ea0070aep640 | Pituitary and Neuroendocrinology | ECE2020

Looking for cyclic cushing’s syndrome

Elena Lopez Alaminos Maria , Gonzalez Fernandez Mikel , Almendra Alvarado Rosas Karol , Serrano Urzaiz Leticia , Martínez García María , Trincado Pablo , de Diego Garcia Patricia

Introduction: Cyclic Cushing´s syndrome (CCS) is a rare disorder with a wide clinical variability, characterized by repeated episodes of cortisol excess and periods of normal or even low cortisol secretion. Different periodical diagnostic tests are required to confirm hypercortisolism and thereafter imaging techniques and laboratory studies can be performed to localize the cause.Case report: A 17-year-old female patient with a personal history of ad...

ea0073aep701 | Thyroid | ECE2021

Grave’s disease in a patient with thyroid hemiagenesis

Jane Pang Eleanor , Aminath Aifa Aboobakuru1 , Sardar Muhammad Shoaib Khan1 , Larsen Niels

IntroductionWe present the case of a 50-year-old lady who was referred to the endocrine clinic with a clinical and biochemical picture suggestive of severe thyrotoxicosis. CT scan of thorax, abdomen and pelvis (CT TAP) was performed to rule out malignancy, which showed left lobe agenesis.Case50-year-old lady presented to the GP with hyperhidrosis and unintentional weight loss. She also reported symptoms of le...

ea0073yi1 | Young Investigator Awards | ECE2021

Circulating myomiRNAs as biomarkers of Cushing’s syndrome

Pivonello Claudia , Patalano Roberta , Negri Mariarosaria , Montò Tatiana , Amatrudo Feliciana , Paola Nicola Di , Iacono Marina , Simeoli Chiara , Ferrigno Rosario , Solari Domenico , Angelis Cristina De , Auriemma Renata Simona , Cappabianca Paolo , Colao Annamaria , Pivonello Rosario

Cushing’s syndrome (CS) is a rare endocrine disease caused by a chronic exposure to endogenous cortisol or exogenous glucocorticoids (GCs). Among multiple comorbidities, impairment of skeletal muscle mass and strength affects 40–70% of patients with active CS and persist even after long-term disease remission. In pathological conditions, GCs excess sustain muscle atrophy and weakness affecting type II muscle fibers. Muscle-specific microRNAs, defined myomiRs, are in...

ea0090p324 | Calcium and Bone | ECE2023

Non-genetic, non-pharmacologic risk factors for osteoporosis: an umbrella review of observational studies

Christou Maria , Markozannes Georgios , Christou Evangelos , Oei Ling , Tigas Stelios , Cianferotti Luisella , Goulis Dimitrios , Karasik David , Makitie Outi , Rivadeneira Fernando , Kiel Douglas , Ntzani Evangelia

Introduction: Osteoporosis is a prevalent skeletal disease associated with increased fracture risk, morbidity, and mortality. Several meta-analyses have investigated the association between non-genetic, non-pharmacologic factors and osteoporosis risk.Purpose: We aimed to perform an umbrella review of the literature to systematically evaluate the available evidence.Methods: Meta-analyses of observational studies evaluating the assoc...

ea0073aep415 | General Endocrinology | ECE2021

Cushing’s syndrome: Do Cushing’s patients have similar diagnostic and treatment journeys and outcomes to mine?

McBride Margaret

BackgroundHaving experienced Cushing’s syndrome and disease, this author is now a Doctor of Philosophy student studying these medical conditions with the main aim of finding out if others diagnosed with these illnesses have experienced similar diagnostic and treatment journeys with similar outcomes.MethodAn online 2020 survey was conducted on 86 Cushing’s members of the Pituitary Foundation, (Female...

ea0086p72 | Metabolism, Obesity and Diabetes | SFEBES2022

A novel compound heterozygous variant of Gitelman’s syndrome in a patient with Sjorgren’s syndrome: latent rather than acquired?

Tellier Genevieve , Wood Ffion , Searell Catrin , Head Simeon , Wilton Anthony

Gitelman’s syndrome (GS) is an autosomal recessive renal tubular disorder caused by mutations of the SLC12A3 gene coding for the thiazide-sensitive sodium chloride co-transporter (NCCT). Hypokalaemia, hypomagnesaemia, hypocalciuria and metabolic alkalosis are consequent. Sjorgren’s syndrome (SS) is a connective tissue disorder primarily affecting lacrimal and salivary glands resulting in sicca complex. The coincidental presence of both syndromes is rare. A 28 year ol...